Lung Cancer
A randomized, phase 3, open-label study to evaluate sigvotatug vedotin compared with docetaxel in adult participants with previously treated non-small cell lung cancer (Be6A Lung-01)
- Details
ClinicalTrials.gov ID:
NCT06012435
Diagnosis Type:
NA
USOR Number:
- Address
,
P: